Age Moderates the Impact of TRAbs on Thyroid Hormones and Hepatic Function in Patients with Graves' Disease

被引:2
|
作者
Guo, Kai [1 ]
Ling, Hongwei [2 ]
Zhou, Xiaoyan [1 ]
Ying, Changjiang [2 ]
机构
[1] Xuzhou Med Univ, Grad Sch, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Dept Endocrinol, Affiliated Hosp, 99 West Huai Hai Rd, Xuzhou 221000, Jiangsu, Peoples R China
基金
俄罗斯科学基金会;
关键词
Graves' disease; thyrotropin receptor antibodies; thyroid hormone; hepatic function; LIVER-FUNCTION TESTS; THYROTROPIN RECEPTOR; INCREASED MORTALITY; SERIAL CHANGES; HYPERTHYROIDISM; DYSFUNCTION; MITOCHONDRIA; PREVALENCE; MANAGEMENT; DIAGNOSIS;
D O I
10.1055/a-1510-9100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyrotropin receptor antibodies (TRAbs) play a significant role in the course of hepatic dysfunction (HDF) in patients with Graves' disease (GD). However, few studies have considered the factors that influence the relationships among TRAbs, thyroid hormone levels, and hepatic function in subjects with newly diagnosed GD. Here we investigated the associations of TRAbs with thyroid hormones and hepatic function and assessed potential factors that can influence these associations among patients with GD. A total of 368 patients newly diagnosed with GD were collected in this cross-sectional study. Patients who had received antithyroid drugs, radioactive iodine, or surgery were excluded. Levels of TRAbs and thyroid hormones and hepatic function were recorded. Linear and binary logistic regression analysis models were applied to investigate associations among these variables after adjusting for confounding characteristics. There was a significant difference in TRAbs indices between the HDF and normal hepatic function groups (p <0.05). After adjusting for confounders, the relationship between TRAbs and thyroid hormones was nonlinear, showing a curve with an initial positive slope and a subsequent flattening (p <0.05). Higher TRAbs were associated with HDF [odds ratio (OR) 1.036, 95% confidence interval (CI) 1.018-1.053 per 1-IU/l increase]. These associations were modified by age, but not by gender, smoking status, Graves' orbitopathy, thyroid-peroxidase antibody levels, or thyroglobulin antibody levels. In younger patients, increasing TRAbs were correlated with higher thyroid hormones and HDF (OR 1.034, 95% CI 1.017-1.052) per1-IU/l increase). In older patients, TRAbs were not correlated with thyroid hormones or HDF (OR 1.024, 95% CI 0.993-1.056) per 1-IU/l increase. Age can affect the impact of TRAbs on thyroid hormone levels and hepatic function in GD. TRAb measurement can have good predictive value in younger patients.
引用
收藏
页码:453 / 460
页数:8
相关论文
共 50 条
  • [1] Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease
    Bano, Arjola
    Gan, Earn
    Addison, Caroline
    Narayanan, Kilimangalam
    Weaver, Jolanta U.
    Tsatlidis, Vasileios
    Razvi, Salman
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (05) : 1378 - 1385
  • [2] Age moderates the associations between TRAbs, free T3 and outcomes of Graves' disease patients with radioactive iodine treatment
    Lu, Lusi
    Gao, Chenlu
    Zhang, Nan
    CLINICAL ENDOCRINOLOGY, 2021, 94 (02) : 303 - 309
  • [3] Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients
    Araruna, Larisse Vieira Mendes
    de Oliveira, Daniela Camargo
    Pereira, Monica Corso
    Moura Neto, Arnaldo
    Tambascia, Marcos Antonio
    Zantut-Wittmann, Denise Engelbrecht
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [4] Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease
    Park, Joonseon
    An, Solji
    Bae, Ja Seong
    Kim, Jeong Soo
    Kim, Kwangsoon
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [5] Efficacy of Anti-Thyroid Medications in Patients with Graves' Disease
    Mahzari, Moeber Mohammed
    Alanazi, Manal Muteb
    Alabdulkareem, Yara Mohammed
    Alharbi, Wesal Abdullah
    Alzahrani, Aram Saeed
    Alqahtani, Norah Abdullah
    Ajwah, Ibrahim Mahmoud
    Ardah, Husam I.
    BMC ENDOCRINE DISORDERS, 2024, 24 (01)
  • [6] Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves' disease
    Suzuki, Nami
    Noh, Jaeduk Yoshimura
    Kozaki, Ai
    Watanabe, Natsuko
    Yoshihara, Ai
    Fukushita, Miho
    Matsumoto, Masako
    Imai, Hideyuki
    Hiruma, Shigenori
    Ichikawa, Masahiro
    Koshibu, Masakazu
    Sankoda, Akiko
    Hirose, Rei
    Inoue, Toshu
    Sugino, Kiminori
    Ito, Koichi
    ENDOCRINE JOURNAL, 2025, 72 (01) : 103 - 113
  • [7] Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study
    Yoon, Jee Hee
    Jin, Meihua
    Kim, Mijin
    Hong, A. Ram
    Kim, Hee Kyung
    Kim, Bo Hyun
    Kim, Won Bae
    Shong, Young Kee
    Jeon, Min Ji
    Kang, Ho-Cheol
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (06) : 1268 - 1276
  • [8] Thyroid vascularization is an important ultrasonographic parameter in untreated Graves' disease patients
    Vita, Roberto
    Di Bari, Flavia
    Perelli, Sarah
    Capodicasa, Giovanni
    Benvenga, Salvatore
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2019, 15 : 65 - 69
  • [9] Changes in the thyroid function of Graves' disease patients treated by subtotal thyroidectomy
    Sugino, Kiminori
    Ito, Koichi
    Nagahama, Mitsuji
    Kitagawa, Wataru
    Shibuya, Hiroshi
    Ohlcuwa, Keiko
    Yano, Yukiko
    Uruno, Takashi
    Akaishi, Junko
    Suzuki, Akifumi
    Masaki, Chie
    Ito, Kunihiko
    ENDOCRINE JOURNAL, 2012, 59 (12) : 1115 - 1120
  • [10] The prevalence and significance of nonuniform thyroid radio-isotope uptake in patients with Graves' disease
    Abdalaziz, Altayeb
    Vanka, Ramesh
    Bartholomew, Peter
    Vennart, Nicholas
    Vernazza, Jonathan
    Stewart, Kathryn
    Tsatlidis, Vasileios
    Narayanan, Kilimangalam
    Weaver, Jolanta U.
    Razvi, Salman
    CLINICAL ENDOCRINOLOGY, 2022, 97 (01) : 100 - 105